Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function

被引:216
|
作者
Schebesta, Alexandra [1 ]
McManus, Shane [1 ]
Salvagiotto, Giorgia [1 ]
Delogu, Alessio [1 ]
Busslinger, Georg A. [1 ]
Busslinger, Meinrad [1 ]
机构
[1] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.immuni.2007.05.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transcription factor Pax5 represses B lineage-inappropriate genes and activates B cell-specific genes in B lymphocytes. Here we have identified 170 Pax5-activated genes. Conditional mutagenesis demonstrated that the Pax5-regulated genes require continuous Pax5 activity for normal expression in pro-13 and mature B cells. Expression of half of the Pax5-activated genes is either absent or substantially reduced upon Pax5 loss in plasma cells. Direct Pax:5 target genes were identified based on their protein synthesis-independent activation by a Pax5-estrogen receptor fusion protein. Chromatin immunoprecipitation (ChIP) of Pax5 together with chromatin profiling by ChIP-on-chip analysis demonstrated that Pax5 directly activates the chromatin at promoters or putative enhancers of Pax5 target genes. The Pax5-activated genes code for key regulatory and structural proteins involved in B cell signaling, adhesion, migration, antigen presentation, and germinal-center B cell formation, thus revealing a complex regulatory network that is activated by Pax5 to control B cell development and function.
引用
收藏
页码:49 / 63
页数:15
相关论文
共 50 条
  • [1] Control of B-cell immunity and leukemia by the transcription factor Pax5
    Busslinger, M.
    Smeenk, L.
    Malin, S.
    Schindler, K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 998 - 999
  • [2] Hands-on regulation of B cell development by the transcription factor Pax5
    Hagman, James
    Lukin, Kara
    IMMUNITY, 2007, 27 (01) : 8 - 10
  • [3] The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells
    McManus, Shane
    Ebert, Anja
    Salvagiotto, Giorgia
    Medvedovic, Jasna
    Sun, Qiong
    Tamir, Ido
    Jaritz, Markus
    Tagoh, Hiromi
    Busslinger, Meinrad
    EMBO JOURNAL, 2011, 30 (12): : 2388 - 2404
  • [4] Pax5: the guardian of B cell identity and function
    Cobaleda, Cesar
    Schebesta, Alexandra
    Delogu, Alessio
    Busslinger, Meinrad
    NATURE IMMUNOLOGY, 2007, 8 (05) : 463 - 470
  • [5] Pax5: the guardian of B cell identity and function
    César Cobaleda
    Alexandra Schebesta
    Alessio Delogu
    Meinrad Busslinger
    Nature Immunology, 2007, 8 : 463 - 470
  • [6] Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers
    Palmisano, WA
    Crume, KP
    Grimes, MJ
    Winters, SA
    Toyota, M
    Esteller, M
    Joste, N
    Baylin, SB
    Belinsky, SA
    CANCER RESEARCH, 2003, 63 (15) : 4620 - 4625
  • [7] PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells
    Bougel, Stephanie
    Renaud, Stephanie
    Braunschweig, Richard
    Loukinov, Dmitri
    Morse, Herbert C., III
    Bosman, Fred T.
    Lobanenkov, Victor
    Benhattar, Jean
    JOURNAL OF PATHOLOGY, 2010, 220 (01): : 87 - 96
  • [8] Rack1 regulates B-cell development and function by binding to and stabilizing the transcription factor Pax5
    Zhang, Xueting
    Ma, Chenke
    Lu, Yuchen
    Wang, Jing
    Yun, Hongfang
    Jiang, Hui
    Wu, Mengyao
    Feng, Xiaoyao
    Gai, Wenbin
    Xu, Guanglei
    Deng, Hongbin
    Feng, Jiannan
    Liu, Wanli
    Shi, Taoxing
    Cheng, Qianqian
    Zhang, Jiyan
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (11) : 1282 - 1295
  • [9] TUMOR SUPPRESSIVE FUNCTION OF B -CELL TRANSCRIPTION FACTOR PAX5 IN KSHV-INFECTED PRIMARY EFFUSION LYMPHOMA
    Goto, Hiroki
    Kariya, Ryusho
    Kudo, Eriko
    Katano, Harutaka
    Okada, Seiji
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [10] Mutations in the B-Cell transcription factor PAX5 found in B-Progenitor acute lymphoblastic leukemia impair normal PAX5 activity.
    Miller, Christopher B.
    Mullighan, Charles G.
    Downing, James R.
    BLOOD, 2006, 108 (11) : 185A - 185A